Prime Medicine, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
60 FIRST ST., CAMBRIDGE, MA, 02141
Mailing Address
60 FIRST ST., CAMBRIDGE, MA, 02141
Phone
617-465-0013
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
$342.73M
Total Assets
$182.48M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 3, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | November 14, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 12, 2025 | View on SEC |
| 8-K Current report of material events | November 7, 2025 | View on SEC |
Annual Reports
10-K
March 3, 2026
- Developing Prime Editing, a revolutionary gene editing technology for precise genetic mutation correction.
- Initiated Phase 1/2 clinical trials for lead program PMO-101 in Q4 2023, with initial patient dosing completed.
Related Companies
Companies in the same industry (SIC: 2836)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Vaxcyte, Inc.
PCVX
Biological Products, (No Diagnostic Substances)
RECURSION PHARMACEUTICALS, INC.
RXRX
Biological Products, (No Diagnostic Substances)
MeiraGTx Holdings plc
MGTX
Biological Products, (No Diagnostic Substances)
Ginkgo Bioworks Holdings, Inc.
DNA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.